
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
SAP 49 CRISPR/Cas9 KO Plasmid (h2) | sc-407057-KO-2 | 20 µg | $397.00 |
SF3B4 encodes splicing factor 3B subunit 4 (SAP 49), a core component of the U2 snRNP within the SF3b complex that promotes accurate recognition of the branch point and 3′ splice site during pre-mRNA splicing. By helping assemble and stabilize spliceosome A and B complexes, SAP 49 influences transcript isoform selection and supports coordinated gene expression programs linked to cell-cycle progression, DNA damage responses, and differentiation. Disruption of spliceosomal fidelity can drive widespread alternative splicing changes and proteome remodeling, making SF3B4 a useful node for studying RNA processing networks in human cells. Altered SF3B4 expression and spliceosome dysfunction have been associated with pathological states in which aberrant splicing contributes to cellular stress responses and dysregulated growth.
SAP 49 CRISPR/Cas9 KO Plasmid (h2) is a pool of plasmids designed for targeted disruption of the SF3B4 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the SF3B4 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the SF3B4 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish SAP 49 protein expression.
This CRISPR knockout system enables efficient generation of SF3B4-deficient cell models for investigation of SAP 49 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.